J&J GMP investigation
U.S. government will not intervene in a qui tam suit filed against Johnson & Johnson by a former employee at its Ortho Biologics plant in Manati, Puerto Rico, but FDA's Office of Criminal Investigations is continuing its inquiry, firm says. The former employee claims he was pressured to falsify documents and then suspended prior to an interview with FDA inspectors (1"The Pink Sheet" July 22, p. 11)...
You may also be interested in...
Johnson & Johnson is recommending intravenous administration of Eprex (epoetin alfa) over subcutaneous administration in chronic renal failure patients in order to decrease the incidence of pure red blood cell aplasia in a July 17 "Dear Doctor" letter to physicians in the EU
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.